How Mark Cuban's Cost Plus Drugs is revolutionizing pharma (w/ CEO Alex Oshmyansky) | Rapid Response

About Alex Oshmyansky

• Founder & CEO, Mark Cuban Cost Plus Drug Co., revolutionizing drug pricing transparency (2022-24)
• MD from Duke, PhD in Mathematics from Oxford as a Marshall Scholar, BA at age 18
• Trained at Harvard (surgery), Johns Hopkins (pediatric radiology), Stanford adjunct faculty
• Recipient, 2024 Rapid Response award at Masters of Scale Summit for industry disruption
• Previously founded Altitude Medical; 14+ years reducing hospital infections